Torrent Pharma to acquire Unichem’s India business


Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd has said that  Torrent has entered into a definite agreement with Unichem to acquire  its branded business of Nepal and India for about Rs.3,600 crore.

The transaction is expected to close by the end of 2017.

Unichem’s India business comprises of a portfolio of more than 120 brands it sells in India and Nepal.

Torrent will fund the acquisition through a mix of internal accruals
and bank borrowings.

The acquisition will add a brand of Rs. 200 crores.